MX9300406A - AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM. - Google Patents
AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM.Info
- Publication number
- MX9300406A MX9300406A MX9300406A MX9300406A MX9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- preparation
- azabiciclic
- procedures
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a un derivados azabicílicos, procedimientos para su preparación, composiciones farmacéutica que contienen estos derivados y su terapia, en particular como antagonistas del canal de calcio.The present invention relates to azabicylic derivatives, methods for their preparation, pharmaceutical compositions containing these derivatives and their therapy, in particular as calcium channel antagonists.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201751A GB9201751D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9300406A true MX9300406A (en) | 1994-07-29 |
Family
ID=10709351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9300406A MX9300406A (en) | 1992-01-28 | 1993-01-26 | AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0625981A1 (en) |
JP (1) | JPH07503462A (en) |
KR (1) | KR950700305A (en) |
AU (1) | AU3364593A (en) |
CA (1) | CA2128536A1 (en) |
GB (1) | GB9201751D0 (en) |
MX (1) | MX9300406A (en) |
WO (1) | WO1993015080A1 (en) |
ZA (1) | ZA93549B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
UY25225A1 (en) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS |
AU1600599A (en) | 1998-02-27 | 1999-09-15 | Warner-Lambert Company | Heterocyclic substituted aniline calcium channel blockers |
US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
SI1345937T1 (en) | 2000-12-22 | 2006-02-28 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as m3 antagonists |
ES2203327B1 (en) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | NEW QUINUCLIDINE CARBAMATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
ES2204295B1 (en) | 2002-07-02 | 2005-08-01 | Almirall Prodesfarma, S.A. | NEW DERIVATIVES OF QUINUCLIDINE-AMIDE. |
CN101883771A (en) | 2007-10-01 | 2010-11-10 | 科门蒂斯公司 | Rubane-4-ylmethyl 1H-indole-3-carboxylic acid the ester derivative that is used for the treatment of Alzheimer as alpha 7 nicotinic acetylcholine receptor ligands |
US9434724B2 (en) | 2014-07-11 | 2016-09-06 | Alpharmagen, Llc | Quinuclidines for modulating alpha 7 activity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1250534A (en) * | 1969-03-03 | 1971-10-20 | ||
GB9005737D0 (en) * | 1990-03-14 | 1990-05-09 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-01-28 GB GB929201751A patent/GB9201751D0/en active Pending
-
1993
- 1993-01-26 MX MX9300406A patent/MX9300406A/en unknown
- 1993-01-26 ZA ZA93549A patent/ZA93549B/en unknown
- 1993-01-27 WO PCT/GB1993/000174 patent/WO1993015080A1/en not_active Application Discontinuation
- 1993-01-27 EP EP93902470A patent/EP0625981A1/en not_active Withdrawn
- 1993-01-27 JP JP5513048A patent/JPH07503462A/en active Pending
- 1993-01-27 CA CA002128536A patent/CA2128536A1/en not_active Abandoned
- 1993-01-27 AU AU33645/93A patent/AU3364593A/en not_active Abandoned
-
1994
- 1994-07-27 KR KR1019940702589A patent/KR950700305A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1993015080A1 (en) | 1993-08-05 |
AU3364593A (en) | 1993-09-01 |
EP0625981A1 (en) | 1994-11-30 |
JPH07503462A (en) | 1995-04-13 |
CA2128536A1 (en) | 1993-08-05 |
KR950700305A (en) | 1995-01-16 |
ZA93549B (en) | 1994-09-22 |
GB9201751D0 (en) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9300407A (en) | AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION. | |
AR005703A1 (en) | SUBSTITUTED OXAZOLIDINONES, PROCEDURE FOR THE PREPARATION, USE OF THE SAME TO PREPARE MEDICINES AND MEDICINES THAT CONTAIN THEM | |
GT199900102A (en) | PHENOXIPROPANOLAMINES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2144192T3 (en) | NEW DERIVATIVES OF 1-PHENYL-2-DIMETHYL-AMINO-METHYL-CICLOHEXAN-1-OL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
MX9301929A (en) | DERIVATIVES OF PIRIMIDINE AND PROCEDURES FOR ITS PREPARATION. | |
AR020019A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF BREAST CANCER | |
MX9400166A (en) | VEGETABLE PROTEIN MICROSPHERES, HYDROLYZED, MODIFIED AND METHODS FOR THEIR PREPARATION AND USE. | |
MX9204268A (en) | A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME. | |
PA8479201A1 (en) | DERIVATIVES OF HYDROXY ACID-HYDROXAMIC PIPECOLATE | |
ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
ES2018478B3 (en) | A SYSTEM TO PREPARE A DENTAL DESENSITIZING COMPOSITION. | |
AR008991A1 (en) | DIMETHYL- (3-ARYL-BUT-3-ENYL) -AMINE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND APPLICATION OF THEM | |
BR9608488A (en) | Use of vitamin d4 derivatives in the treatment of cancer | |
ES2061688T3 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION. | |
IL64292A0 (en) | D-homosteroids,their manufacture and pharmaceutical compositions containing them | |
MX9304793A (en) | GLICANS OF IMMUNO-STIMULATING ACTIVITY. | |
MX9202152A (en) | DERIVATIVES OF INDOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. | |
MX9300406A (en) | AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM. | |
MX9303572A (en) | PROTEASE INHIBITORS OF THE HUMAN IMMUNODEFICIENCY SYNDROME, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM. | |
MX9301157A (en) | DERIVATIVES OF BENCIMIDAZOLONE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2148458T3 (en) | DERIVATIVES OF FENIL-4-THIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2127263T3 (en) | NEW TRIEN-CHROMENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2052484T1 (en) | N- (5-TIOXO-L-PROLIL) -L-CYSTEINE, ITS DERIVATIVES, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
MX9307203A (en) | STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED. | |
IT1200944B (en) | XANTHINIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR THERAPEUTIC USE |